Authors: Wai, JS Egbertson, MS Payne, LS Fisher, TE Embrey, MW Tran, LO Melamed, JY Langford, HM Guare, JP Zhuang, LG Grey, VE Vacca, JP Holloway, MK Naylor-Olsen, AM Hazuda, DJ Felock, PJ Wolfe, AL Stillmock, KA Schleif, WA Gabryelski, LJ Young, SD

Citation: Js. Wai et al., 4-aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells, J MED CHEM, 43(26), 2000, pp. 4923-4926

Authors: Dorsey, BD McDonough, C McDaniel, SL Levin, RB Newton, CL Hoffman, JM Darke, PL Zugay-Murphy, JA Emini, EA Schleif, WA Olsen, DB Stahlhut, MW Rutkowski, CA Kuo, LC Lin, JH Chen, IW Michelson, SR Holloway, MK Huff, JR Vacca, JP

Citation: Bd. Dorsey et al., Identification of MK-944a: A second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors, J MED CHEM, 43(18), 2000, pp. 3386-3399

Authors: Schmidt, A Vogel, R Holloway, MK Rutledge, SJ Friedman, O Yang, ZL Rodan, GA Friedman, E

Citation: A. Schmidt et al., Transcription control and neuronal differentiation by agents that activatethe LXR nuclear receptor family, MOL C ENDOC, 155(1-2), 1999, pp. 51-60